The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Adipocyte Fatty Acid–Binding Protein Is a Plasma Biomarker Closely Associated with Obesity and Metabolic Syndrome
Abstract
Background: Adipocyte fatty acid–binding protein (A-FABP) is traditionally thought to be a cytosolic fatty acid chaperone expressed in adipocytes. Mice with targeted disruption of the A-FABP gene exhibit a striking phenotype with strong protection from insulin resistance, hyperglycemia, and atherosclerosis. The clinical relevance of these findings remains to be confirmed. Methods: We used tandem mass spectrometry–based proteomic analysis to identify proteins secreted from adipocytes and present in human serum. We measured serum A-FABP concentrations in 229 persons (121 men and 108 women; age range, 33–72 years), including 100 lean [body mass index (BMI) <25 kg/m2] and 129 overweight/obese individuals (BMI >25 kg/m2) selected from a previous cross-sectional study. Results: A-FABP was released from adipocytes and was abundantly present in human serum. Mean (SD) circulating concentrations of A-FABP were significantly higher in overweight/obese than in lean persons [32.3 (14.8) vs 20.0 (9.8) μg/L; P <0.001]. Age- and sex-adjusted serum A-FABP concentrations correlated positively (P <0.005) with waist circumference, blood pressure, dyslipidemia, fasting insulin, and the homeostasis model assessment insulin resistance index. Moreover, we observed a significant increase in A-FABP concentrations corresponding with increases in the number of components of the metabolic syndrome (P <0.05). Conclusions: A-FABP is a circulating biomarker closely associated with obesity and components of the metabolic syndrome, and measurement of serum concentrations of A-FABP might be useful for clinical diagnosis of obesity-related metabolic and cardiovascular disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Adipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606 · cited 1×
“Discordant production by adipose tissue of these substances, such as decreased adiponectin and increased tumor necrosis factor- , interleukin-6, plasminogen activator inhibitor 1, and free fatty acids, contributes to the development of metabolic syndrome (6, 7).”
BackgroundAdipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
Obesity, Metabolic Syndrome, and Cardiovascular Disease
Grundy, S. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0372 · Cited by 1,371
Hotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome
TRUJILLO, M. E., & SCHERER, P. E. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01426.x · Cited by 769
Gender differences in fat metabolism
Blaak, E. (2001) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200111000-00006 · Cited by 709
Makowski, L., Boord, J. B., Maeda, K., Babaev, V. R., Uysal, K. T., Morgan, M. A., Parker, R. A., Suttles, J., Fazio, S., Hotamisligil, G. S., et al. (2001) · Nature Medicine · doi:10.1038/89076 · Cited by 686
Metabolic Syndrome: A Clinical and Molecular Perspective
Moller, D. E., & Kaufman, K. D. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104751 · Cited by 631
Fatty acid-binding proteins as plasma markers of tissue injury
Pelsers, M. M. A. L., Hermens, W. T., & Glatz, J. F. C. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.09.001 · Cited by 488
Maeda, K., Cao, H., Kono, K., Gorgun, C. Z., Furuhashi, M., Uysal, K. T., Cao, Q., Atsumi, G., Malone, H., Krishnan, B., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.008 · Cited by 477
Serum Resistin (FIZZ3) Protein Is Increased in Obese Humans
Degawa-Yamauchi, M., Bovenkerk, J. E., Juliar, B. E., Watson, W., Kerr, K., Jones, R., Zhu, Q., & Considine, R. V. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021808 · Cited by 476
Xu, A., Chan, K. W., Hoo, R. L. C., Wang, Y., Tan, K. C. B., Zhang, J., Chen, B., Lam, M. C., Tse, C., Cooper, G. J. S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414231200 · Cited by 419
Self-citationMakowski, L., Brittingham, K. C., Reynolds, J. M., Suttles, J., & Hotamisligil, G. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413788200 · Cited by 410
Vogel Hertzel, A., & Bernlohr, D. A. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00257-5 · Cited by 404
Wajchenberg, B. L., Giannella-Neto, D., da Silva, M. E., & Santos, R. F. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-38256 · Cited by 395
Metabolic syndrome and cardiovascular disease
Qiao, Q., Gao, W., Zhang, L., Nyamdorj, R., & Tuomilehto, J. (2007) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/000456307780480963 · Cited by 376
Wang, Y., Xu, A., Knight, C., Xu, L. Y., & Cooper, G. J. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200601200 · Cited by 342
Self-citationImproved Glucose and Lipid Metabolism in Genetically Obese Mice Lacking aP2
Uysal, K. T., Scheja, L., Wiesbrock, S. M., Bonner‐Weir, S., & Hotamışlıgil, G. S. (2000) · Endocrinology · doi:10.1210/en.141.9.3388 · Cited by 324
A role for preadipocytes as macrophage‐like cells
COUSIN, B., MUNOZ, O., ANDRE, M., FONTANILLES, A. M., DANI, C., COUSIN, J. L., LAHARRAGUE, P., CASTEILLA, L., & PÉNICAUD, L. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.305 · Cited by 320
Fatty Acid Binding Proteins—The Evolutionary Crossroads of Inflammatory and Metabolic Responses
Makowski, L., & Hotamisligil, G. S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.9.2464s · Cited by 311
Coe, N. R., Simpson, M. A., & Bernlohr, D. A. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32133-7 · Cited by 296
Xu, A., Lam, M. C., Chan, K. W., Wang, Y., Zhang, J., Hoo, R. L. C., Xu, J. Y., Chen, B., Chow, W.-S., Tso, A. W. K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408452102 · Cited by 269
Self-citationRole of the Fatty Acid Binding Protein mal1 in Obesity and Insulin Resistance
Maeda, K., Uysal, K. T., Makowski, L., Görgün, C. Z., Atsumi, G., Parker, R. A., Brüning, J., Hertzel, A. V., Bernlohr, D. A., & Hotamisligil, G. S. (2003) · Diabetes · doi:10.2337/diabetes.52.2.300 · Cited by 224
Lieberman, J. M., Sacchettini, J., Marks, C., & Marks, W. H. (1997) · Surgery · doi:10.1016/s0039-6060(97)90363-9 · Cited by 217
Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.
Scheja, L., Makowski, L., Uysal, K. T., Wiesbrock, S. M., Shimshek, D. R., Meyers, D. S., Morgan, M., Parker, R. A., & Hotamisligil, G. S. (1999) · Diabetes · doi:10.2337/diabetes.48.10.1987 · Cited by 217
Adipobiology of Disease: Adipokines and Adipokine-Targeted Pharmacology
Chaldakov, G., Stankulov, I., Hristova, M., & Ghenev, P. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033455152 · Cited by 212
Boord, J. B., Maeda, K., Makowski, L., Babaev, V. R., Fazio, S., Linton, M. F., & Hotamisligil, G. S. (2004) · Circulation · doi:10.1161/01.cir.0000141735.13202.b6 · Cited by 193
Pelton, P. D., Zhou, L., Demarest, K. T., & Burris, T. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1071 · Cited by 186
Fu, Y., Luo, N., Lopes-Virella, M. F., & Garvey, W. T. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00305-2 · Cited by 185
Thomas, G. N., Ho, S.-Y., Janus, E. D., Lam, K. S. L., Hedley, A. J., & Lam, T. H. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.07.022 · Cited by 178
Self-citationLiu, M. Y., Xydakis, A. M., Hoogeveen, R. C., Jones, P. H., Smith, E. O., Nelson, K. W., & Ballantyne, C. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.047084 · Cited by 178
Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis
Boord, J. B., Fazio, S., & Linton, M. F. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200204000-00005 · Cited by 170
Inflammation, insulin resistance, and obesity
Ferroni, P., Basili, S., Falco, A., & Davì, G. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0082-x · Cited by 151
Kazemi, M. R., McDonald, C. M., Shigenaga, J. K., Grünfeld, C., & Feingold, K. R. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000159163.52632.1b · Cited by 146
Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages
Fu, Y., Luo, N., & Lopes-Virella, M. F. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32363-4 · Cited by 136
Xu, A., Yin, S., Wong, L. S. L., Chan, K. W., & Lam, K. S. L. (2003) · Endocrinology · doi:10.1210/en.2003-1140 · Cited by 120
Self-citationWunderlich, M., Hanhoff, T., Goertler, M., Spener, F., Glatz, J. F. C., Wallesch, C.-W., & Pelsers, M. M. A. L. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0725-z · Cited by 102
Investigation of in vivo fatty acid metabolism in AFABP/aP2−/−mice
Baar, R. A., Dingfelder, C. S., Smith, L. A., Bernlohr, D., Wu, C., Lange, A. J., & Parks, E. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00256.2004 · Cited by 98
ROSENBAUM, M. S., Pietrobelli, A., Vasselli, J., Heymsfield, S. B., & Leibel, R. L. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801730 · Cited by 93
Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages
Llaverı́as, G., Noé, V., Peñuelas, S., Vázquez‐Carrera, M., Sánchez, R. M., Laguna, J. C., Ciudad, C. J., & Alegret, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.021 · Cited by 90
Tan, K. C. B., Wat, N. M. S., Tam, S., Janus, E. D., Lam, T., & Lam, K. S. L. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2323 · Cited by 87
Self-citationPelsers, M. M. A. L., Morovat, A., Alexander, G., Hermens, W. T., Trull, A. K., & Glatz, J. F. C. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.11.2055 · Cited by 81
Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum
Wang, Y., Lü, G., Wong, W. P. S., Vliegenthart, J. F. G., Gerwig, G. J., Lam, K. S. L., Cooper, G. J. S., & Xu, A. (2004) · PROTEOMICS · doi:10.1002/pmic.200400826 · Cited by 76
Self-citationCentral obesity predicts the worsening of glycemia in southern Chinese
Wat, N., Lam, T., Janus, E., & Lam, K. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801834 · Cited by 61
Self-citationFatty acid binding proteins stabilize leukotriene A4
Zimmer, J. S. D., Dyckes, D. F., Bernlohr, D., & Murphy, R. C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400240-jlr200 · Cited by 55
Cited by
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Furuhashi, M., & Hotamisligil, G. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2589 · Cited by 1,785
Zhang, X., Yeung, D. C. Y., Karpisek, M., Stejskal, D., Zhou, Z.-G., Liu, F., Wong, R. L. C., Chow, W.-S., Tso, A. W. K., Lam, K. S. L., et al. (2008) · Diabetes · doi:10.2337/db07-1476 · Cited by 908
Self-citationMetabolic functions of FABPs—mechanisms and therapeutic implications
Hotamisligil, G. S., & Bernlohr, D. A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.122 · Cited by 712
Adipocytokines in Obesity and Metabolic Disease
Cao, H. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0339 · Cited by 705
Gregor, M. F., & Hotamisligil, G. S. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r700007-jlr200 · Cited by 586
Metadata
- Authors
- Xu, A., Wang, Y., Xu, J. Y., Stejskal, D., Tam, S., Zhang, J., Wat, N. M., Wong, W. K., & Lam, K. S.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-03-01
- Volume
- 52
- Issue
- 3
- Pages
- 405-413
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2133374684
- Cited by
- 602
- References
- 49
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.